Harvoni

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 61958-1804
  • Package NDC 61958-1804-1
  • Application number NDA212477
  • SPL ID 5fa2f6f7-935b-fb04-e063-6294a90afb0f
  • SPL set ID f4ec77e4-bae8-4db0-b3d5-bde09c5fa075
  • UNII 013TE6E4WV
  • UNII WJ6CA3ZU8B
  • RxCUI 1591943
  • RxCUI 1591949
  • RxCUI 2203895
  • RxCUI 2203897
  • RxCUI 2204100
  • RxCUI 2204102
  • RxCUI 2204103
  • RxCUI 2204104

What the source publishes

Labeler
Gilead Sciences, Inc
Active ingredients
ledipasvir and sofosbuvir
Form
PELLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:61958-1804_5fa2f6f7-935b-fb04-e063-6294a90afb0f
{
  "name": "Harvoni",
  "splId": "5fa2f6f7-935b-fb04-e063-6294a90afb0f",
  "labels": [
    {
      "setId": "f4ec77e4-bae8-4db0-b3d5-bde09c5fa075",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4ec77e4-bae8-4db0-b3d5-bde09c5fa075",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4ec77e4-bae8-4db0-b3d5-bde09c5fa075"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Gilead Sciences, Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "120 PELLET in 1 PACKET (61958-1804-1)",
      "package_ndc": "61958-1804-1",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20280131",
      "marketing_start_date": "20190828"
    }
  ],
  "productId": "61958-1804_5fa2f6f7-935b-fb04-e063-6294a90afb0f",
  "useDomain": "unknown",
  "dosageForm": "PELLET",
  "productNdc": "61958-1804",
  "deaSchedule": null,
  "genericName": "ledipasvir and sofosbuvir",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20280131",
  "activeIngredients": [
    {
      "name": "LEDIPASVIR",
      "strength": "45 mg/1"
    },
    {
      "name": "SOFOSBUVIR",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "NDA212477",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190828",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000191256",
      "N0000185503",
      "N0000190113",
      "N0000191493",
      "N0000191258"
    ],
    "unii": [
      "013TE6E4WV",
      "WJ6CA3ZU8B"
    ],
    "rxcui": [
      "1591943",
      "1591949",
      "2203895",
      "2203897",
      "2204100",
      "2204102",
      "2204103",
      "2204104"
    ],
    "spl_set_id": [
      "f4ec77e4-bae8-4db0-b3d5-bde09c5fa075"
    ],
    "pharm_class_epc": [
      "Hepatitis C Virus NS5A Inhibitor [EPC]",
      "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "P-Glycoprotein Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]",
      "RNA Replicase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Gilead Sciences, Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:61958-1804_5fa2f6f7-935b-fb04-e063-6294a90afb0f"